English | Español
Patient Daily | Mar 12, 2026

Texas Medical Association announces concerns over pharmacy benefit manager consolidation
Patient Daily | Mar 11, 2026

Roche invests $480 million to expand clinical trial capacity in South Korea
Patient Daily | Mar 11, 2026

FDA partially pauses PepGen's phase 2 trial for myotonic dystrophy
Patient Daily | Mar 11, 2026

FDA official seeks hire amid controversy over antidepressant warnings
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
Patient Daily | Mar 11, 2026

Analysts say psychedelics unlikely to dominate depression treatment market
Patient Daily | Mar 11, 2026

UniQure weighs next steps after FDA requests new phase 3 trial for Huntington's gene therapy
Patient Daily | Mar 11, 2026

Targeted mRNA restores fertility in genetically infertile male mice

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Regulatory
A. D. Brady | Mar 30, 2026

Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers releases update on trial law firm political donations
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026